PRESUMED JOSEPH DISEASE - 3 NEW KINDREDS AND RESPONSE TO ANTI-PARKINSON DRUGS

被引：0
作者：
SUBRAMONY, SH
CURRIER, RD
JACKSON, JF
COLLINS, GM
机构：
来源：
ANNALS OF NEUROLOGY | 1990年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：233 / 233
页数：1
相关论文
共 50 条
[31]   REVERSAL OF SOME THERAPEUTIC EFFECTS OF HALOPERIDOL IN SCHIZOPHRENIA BY ANTI-PARKINSON DRUGS [J].
SINGH, M ;
SMITH, JM .
PHARMACOLOGIST, 1971, 13 (02) :207-&
[32]   EVALUATION OF ANTI-PARKINSON DRUGS ON RESERPINE-INDUCED RIGIDITY IN RATS [J].
GOLDSTEIN, JM ;
BARNETT, A ;
MALICK, JB .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1975, 33 (01) :183-188
[33]   Electrochemical studies of ropinirole, an anti-Parkinson's disease drug [J].
Nigovic, Biljana ;
Juric, Sandra ;
Mornar, Ana ;
Malenica, Ines .
JOURNAL OF CHEMICAL SCIENCES, 2013, 125 (05) :1197-1205
[34]   Electrochemical studies of ropinirole, an anti-Parkinson’s disease drug [J].
BILJANA NIGOVIĆ ;
SANDRA JURIĆ ;
ANA MORNAR ;
INES MALENICA .
Journal of Chemical Sciences, 2013, 125 :1197-1205
[35]   Spending trends on neuropsychiatric drugs in Minas Gerais, Brazil: is the offer of anti-parkinson drugs increasing? [J].
Silva Carvalho, Liliany Mara ;
Alves, Jessica de Castro ;
Borges Luz, Tatiana Chama .
CIENCIA & SAUDE COLETIVA, 2021, 26 (08) :3289-3300
[36]   Parkinsonism from methanol poisoning: Benefit from treatment with anti-Parkinson drugs [J].
Davis, LE ;
Adair, JC .
MOVEMENT DISORDERS, 1999, 14 (03) :520-522
[37]   COMPUTATIONAL DESIGNING OF DEFERIPRONE BASED NOVEL DRUGS AS EFFICIENT ANTI-PARKINSON AGENTS [J].
Hassan, A. U. ;
Nkungli, N. K. ;
Guleryuz, C. .
LATIN AMERICAN APPLIED RESEARCH, 2023, 53 (02) :157-162
[38]   INTERACTIONS OF SOME CHOLINOLYTIC ANTI-PARKINSON DRUGS WITH NICOTINE AND OXOTREMORINE ON RAT DIAPHRAGM [J].
DAS, M ;
GANGULY, DK .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1977, 39 (01) :149-152
[39]   ARE PROPHYLACTIC ANTI-PARKINSON DRUGS NECESSARY - CONTROLLED-STUDY OF PROCYCLIDINE WITHDRAWAL [J].
RIFKIN, A ;
QUITKIN, F ;
KANE, J ;
STRUVE, F ;
KLEIN, DF .
ARCHIVES OF GENERAL PSYCHIATRY, 1978, 35 (04) :483-489
[40]   Safinamide - From molecular targets to a new anti-Parkinson drug [J].
Caccia, C. ;
Maj, R. ;
Calabresi, M. ;
Maestroni, S. ;
Faravelli, L. ;
Curatolo, L. ;
Salvati, P. ;
Fariello, R. G. .
NEUROLOGY, 2006, 67 (07) :S18-S23
12345